Phase4 Partners
Overview
Phase4 Partners is a venture capital firm specializing in early-stage and growth-stage investments in the healthcare sector. Founded in 1999 and led by Managing Partner Denise Pollard-Knight, the firm focuses on companies transforming healthcare, including biotechnology, medical devices, digital health, and diagnostics. The team brings together a unique blend of industry expertise, operational experience, and a passion for innovation. The firm's investment strategy emphasizes building enduring partnerships with founders who share a vision of improving global health. Beyond capital, Phase4 Partners provides strategic guidance, operational support, and access to a global network of industry leaders. They have invested over $400 million in 24 companies in both Europe and the US, including notable successes such as Pharmion, Arakis, Proteolix, Albireo, and OncoMed. Phase4 Partners is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).
Investment Focus
- Companies transforming healthcare
- Early-stage and growth-stage companies
- Focus on biotechnology, medical devices, digital health, and diagnostics
Portfolio Companies
Reach Phase4 Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Phase4 Partners
What sectors does Phase4 Partners invest in?
Phase4 Partners invests in Life Sciences, Digital Health, Medical Devices, Diagnostics and Biotechnology, and is based in Westminster, United Kingdom. Phase4 Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does Phase4 Partners invest at?
Phase4 Partners backs companies at Early Stage and Growth, writing cheques of 15M - 30M.
Which regions does Phase4 Partners invest in?
Phase4 Partners invests across United States and United Kingdom.
Who are the partners at Phase4 Partners?
Team members listed for Phase4 Partners include Denise Pollard-Knight (Managing Partner).
What companies has Phase4 Partners invested in?
Phase4 Partners's portfolio includes Pharmion, Arakis, Proteolix, Albireo and OncoMed.
How do I contact Phase4 Partners?
Phase4 Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
